Kenneth D Beaman Selected Research

Proton Pumps (Proton Pump)

10/2020	In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.
9/2017	Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H⁺)-ATPase Inhibitors.
10/2015	Breast cancer associated a2 isoform vacuolar ATPase immunomodulates neutrophils: potential role in tumor progression.
2/2015	Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth D Beaman Research Topics

Disease

15	Neoplasms (Cancer) 10/2020 - 02/2015
7	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2015
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2016
6	Inflammation (Inflammations) 01/2018 - 11/2014
5	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 02/2015
4	Infections 01/2018 - 09/2004
3	Premature Obstetric Labor (Premature Labor) 01/2018 - 10/2015
3	Spontaneous Abortion (Miscarriage) 09/2011 - 08/2002
2	Infertility (Sterility) 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2016 - 02/2015
1	Carcinogenesis 01/2020
1	Leukemia 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Premature Birth (Birth, Premature) 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2016
1	Foreign Bodies (Foreign Body) 01/2016
1	Obesity 12/2015
1	Triple Negative Breast Neoplasms 10/2015
1	Virus Diseases (Viral Diseases) 12/2013
1	Glioblastoma (Glioblastoma Multiforme) 04/2006
1	Glioma (Gliomas) 04/2006
1	Necrosis 09/2004

Drug/Important Bio-Agent (IBA)

13	Adenosine Triphosphatases (ATPase)IBA 10/2020 - 09/2011
10	Protein Isoforms (Isoforms)IBA 10/2020 - 02/2015
7	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 09/2018 - 02/2015
5	CytokinesIBA 01/2020 - 08/2002
4	Proton Pumps (Proton Pump)IBA 10/2020 - 02/2015
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2006
3	Notch ReceptorsIBA 11/2016 - 10/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2015
2	Interleukin-22 (IL-22)IBA 01/2020 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 11/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2016
2	PlatinumIBA 01/2019 - 01/2016
2	LipopolysaccharidesIBA 01/2018 - 01/2016
2	Jagged-1 ProteinIBA 01/2016 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2015
2	delta proteinIBA 01/2016 - 10/2015
2	LigandsIBA 01/2016 - 10/2015
2	Peptidoglycan (Murein)IBA 10/2015 - 12/2013
2	Poly I-CIBA 10/2015 - 12/2013
2	regeneration and tolerance factorIBA 04/2006 - 09/2004
2	Messenger RNA (mRNA)IBA 04/2006 - 09/2004
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Protons (Proton)IBA 10/2020
1	Caspase 3 (Caspase-3)IBA 10/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2020
1	InterleukinsIBA 01/2020
1	IodineIBA 01/2020
1	IodidesIBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Therapeutic UsesIBA 09/2017
1	BenzopyransIBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 11/2016
1	HLA-C Antigens (HLA-C)IBA 02/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	Mifepristone (RU 486)FDA Link 01/2016
1	Platinum Compounds (Compounds, Platinum)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2015
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Cytidine Monophosphate (CMP)IBA 10/2015
1	Toll-Like Receptor AgonistsIBA 03/2015
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	CortactinIBA 02/2015
1	Matrix Metalloproteinases (MMPs)IBA 02/2015
1	Peptide Hydrolases (Proteases)FDA Link 02/2015
1	Actins (F Actin)IBA 02/2015
1	Platelet Activating FactorIBA 11/2014
1	platelet activating factor receptorIBA 11/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2014
1	Immunoglobulins (Immunoglobulin)IBA 05/2005
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2004

Therapy/Procedure

6	Therapeutics 01/2020 - 10/2015
1	Treatment Delay 10/2020
1	Immunotherapy 10/2020
1	Induced Labor 01/2018
1	Transplantation 01/2016
1	Subcutaneous Injections 01/2016